Mohamed Nabulsi, Esq. and Ahmed Gadalla, Esq. co-author article for Medical Economics titled “The Recent Uptick in False Claims Act Investigations Explained”
February 27, 2023
“Under the Health Resources & Services Administration (“HRSA”) Uninsured Program (the “Program”), healthcare providers who conducted COVID-19 testing or provided treatment for uninsured individuals with a COVID-19 primary diagnosis on or after February 4, 2020, or provided COVID-19 vaccine administration on or after December 14, 2020, were entitled to reimbursement through the Program based on […]
Healthcare Client Alert: Uptick in False Claims Act Investigations
February 8, 2023
In the last several months, we have witnessed an uptick in government investigations of laboratories and other providers (audits and Civil Investigative Demands alleging violation of the False Claims Act (“FCA”)) related to the billing of the HRSA Uninsured Program for COVID-19 testing, treatment and vaccine administration (the “Program”). In light of this trend, providers may […]
New Jersey Healthcare Alert: AMA Opposing APNs Expanded Scope of Practice in NJ
January 27, 2023
During the COVID-19 pandemic, Governor Murphy issued Executive Order No. 112, which waived existing practice restrictions for advanced practice nurses (APNs). A proposed New Jersey Senate Bill (S-1522) would go further, permanently expanding the scope of practice for APNs. The AMA is opposed to this bill, based on their position that APNs do not receive […]